Origen, Inc., Gaithersburg, MD). Fetal lymph nodes, spleen, and thymus were processed as previously described (1) . All tissues were extensively washed with sterile phosphate buffered saline (PBS) (> 40 mL per wash and > 5 washes per specimen) prior to harvesting cells. Whole fetal mesenteries were washed in PBS prior to isolation of individual LNs, which were scattered throughout the omentum. A typical fetal mesentery yielded 20-30 LNs and ~10-20 million mononuclear cells. Fetal spleen and thymus were processed by mechanical dispersion in sterile PBS (2% HI FBS) followed by incubation in 0.2 mg/ml collagenase B (Roche Diagnostics, Switzerland) for 1 hour at 37°C. In 2 some cases, red blood cells were removed by additional density centrifugation over a ficoll-hypaque gradient after collagenase digestion.
Analysis of maternal microchimerism. Detection of maternal microchimerism was performed as previously described (2) (3) (4) (5) . Briefly, whole cell suspensions were prepared from processed fetal tissues and from maternal blood samples, and cell pellets were frozen at ~3-5 million cells per tube. DNA was isolated from frozen cell pellets.
Maternal and fetal HLA types (HLA-DR based assays) and insertion/deletion profiles (In/Del assay) were determined. Fetal samples were then analyzed for informative maternal alleles (i.e., maternal polymorphisms not present in the fetus) by quantitative allelespecific real-time polymerase chain reaction (qPCR) for the presence of minute amounts of maternal DNA. The fetal samples were also amplified by qPCR using primers specific to HLA-DQ alpha to determine the concentration of total DNA in each specimen. We estimated the concentration of total DNA and minor-type DNA (i.e., maternal cells) in the fetal samples by comparison of sample cycle thresholds to those from parallel amplification of 10-fold serial dilutions of standards with known cell count.
We divided the concentration of maternal cell DNA by the concentration of total sample DNA to obtain the frequency of maternal cells in each fetal sample. Table 1 in the main text (LN5 had no informative alelle and LN8 and LN15 did not have detectable levels of chimerism). Error bars represent range of chimerism detected using HLA-or In/Del-based assays. (D) Analysis of maternal microchimerism in paired spleens and LNs from three donors. Only one spleen showed detectable levels of microchimerism, which was considerably lower than that detected in LNs. The LNs are less likely to come in contact with maternal cells during tissue harvesting since they are embedded in layers of connective tissue (omentum) within the mesentery. The experiment thus suggests that detection of microchimerism in LNs is not due to maternal contamination during the harvesting of the fetal tissues. (E) Organs from three intact products of conception were dissected and tested for the presence of maternal microchimerism. All three samples had detectable microchimerism, although only one was tested for chimerism in the LNs (which were negative). All three samples were very carefully processed to ensure that fetal tissues were not exposed to maternal cells during tissue harvesting. Blood analyzed in Sample 1 was obtained directly from the interior chamber of the heart. + T Reg cells to cultures at a 1:3 ratio was found to suppress anti-maternal responses to a greater extent than unrelated APCs (n=4). Statistical significance was determined by paired Student's t-test. 
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